Cardiac Biomarkers Market by Type (Myocardial muscle Creatine Kinase (CK-MB), Troponins (T and I), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA), and Others), by Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), by Location of Testing (Point of Care Testing and Laboratory Testing) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030

Cardiac Biomarkers Market

Industry:  Life Sciences & Healthcare | Publish Date: Sep 2020 | No of Pages:  296 | No. Tables:  151 | No. Figures:  136

Market Definition

The global Cardiac Biomarkers Market size was valued at USD 8.42 billion in 2019 and is predicted to reach USD 28.29 billion by 2030, with a CAGR of 11.6% from 2020-2030.

Cardiac biomarkers are protein-based substrates released into the blood stream when the heart is extremely stressed or damaged. Cardiac biomarkers can be traced and measured to diagnose Cardio Vascular Diseases (CVDs) such as Acute Coronary Syndrome (ACS), myocardial infraction, cardiac ischemia, and others.

Cardiac biomarker is an integrated diagnostic approach for prevention of CVDs by monitoring the heart conditions. Due to high sensitivity, it gives rapid results for immediately initiating the diagnostic and treatment procedures.

The adoption of cost-effective Cardiac Point of Care (PoC) testing kits that offer quick results with higher accuracy are gaining momentum over the period, thereby supplementing the growth of cardiac biomarkers market.

Market Dynamics and Trends

According to the data World Health Organization, more than 17.9 million people worldwide, die of Cardiovascular diseases (CVDs), every year. This scenario consequently escalates the demand for advanced healthcare facilities that offer precise diagnostics, monitoring and treatments options for patients suffering from CVDs, thereby propagating the growth of global cardiac biomarkers market.

Furthermore, benefits offered by cardiac biomarkers such as, fast and precise depictions of heart failures after the one-set of chest pain, and high sensitivity of biomarkers test-kit offering precise results; are expected to propagate the growth of global market.

However, limited use of biomarkers test in specific cases, and risk of skeletal injury are the limiting factors expected to slow down the growth of cardiac biomarkers market.

Moreover, multiple options to formulate different combinations for cardiac biomarkers testing, manufacturers offering various customized solutions, and increasing investment in the R&D activities for new clinical research by government and non-government authorities, are the factors anticipated to propel the growth of global market in coming future.

 

Market Segmentations and Scope of the Study

The global cardiac biomarkers market share has been analyzed based on type, application, location of testing and geography.

Based on product type, the cardiac biomarkers market report is segmented into Myocardial muscle Creatine Kinase (CK-MB), Myoglobin, Brain Natriuretic Peptide (BNPs), Troponins (T and I), or NT-proBNP, Ischemia Modified Albumin (IMA), and Others. Based on application, the market is categorized into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others. Based on location of testing, the market is divided into Point of care testing and Laboratory testing. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.

 

Geographical Analysis

North America dominated the global cardiac biomarkers market, and is expected to maintain this trend throughout the forecast period, accounting for the highest market share. This is attributed to well-established healthcare infrastructures and medical laboratories. Moreover, increasing incidences of CVDs due to sedimentary lifestyles, and adoption of PoC gaining momentum, are the factors expected to further propel the market growth in this region.

Asia Pacific region is expected to grow substantially in the global market, owing to increasing accessibility to healthcare facilities, higher prevalence of CVDs due constantly multiplying population, increasing medical tourism, and increasing awareness regarding treatment options.

 

Competitive Landscape

The cardiac biomarkers industry is highly competitive and consists of various market players. Some of the major market players include Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Alere Inc., Bio-Rad Laboratories, Becton, Dickinson and Company, BioMerieux, Beckman Coulter, Randox laboratories, and Thermo Fisher Scientific among others.

An upsurge in R&D activities and new product launches by the key players, is leading the healthcare infrastructure to new heights, thereby creating lucrative opportunities in the global cardiac biomarkers market.

For instance, in September 2019, Abbott, one of the major players in the global market, introduced a test to assist in curing the troponin dilemma. Abbott’s High Sensitivity Troponin-I (hsTnI) blood test measures very low levels of troponin, allowing doctors to assess heart attack in patients within two to four hours of admission. It has achieved a green signal for commercialization in the U.S. to help diagnose heart attacks in men and women.

Key Benefits

  • The cardiac biomarkers market report provides the quantitative analysis of the current market and estimations through 2020-2030 that assists in identifying the prevailing market opportunities to capitalize on.

  • The study comprises a deep dive analysis of the market trend including the current and future trends for depicting the prevalent investment pockets in the market.

  • The report provides detailed information related to key drivers, restraints, opportunities, and their impact on the global market.

  • The report incorporates competitive analysis of the market players along with their market share in the global market.

  • The SWOT analysis and Porters Five Forces model is elaborated in the study of the market.

  • Value chain analysis in the cardiac biomarkers market study provides a clear picture of the stakeholders’ roles.

Cardiac Biomarkers Market Key Segments

By Type

  • Myocardial muscle Creatine Kinase (CK-MB)

  • Troponins (T and I)

  • Myoglobin

  • Brain Natriuretic Peptide (BNPs) or NT-proBNP

  • Ischemia Modified Albumin (IMA)

  • Others

By Application

  • Myocardial Infarction

  • Congestive Heart Failure

  • Acute Coronary Syndrome

  • Atherosclerosis

  • Others

By Location of Testing

  • Point of care testing

  • Laboratory testing

By Geography

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Rest of Europe

  • Asia-Pacific

    • China

    • India

    • Japan

    • Australia

    • Rest of Asia-Pacific

  • RoW

    • Latin America

    • Middle East

    • Africa

Report Scope and Segmentation

Parameters

Details

Analysis Period

2019–2030

Base Year Considered

2020

Forecast Period

2020–2030

Market Size Estimation

Billion (USD)

Market Segmentation

By Type (Creatine Kinase, Troponins, Myoglobin, Natriuretic peptides, Ischemia Modified Albumin, Other Type) By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, Other Application) By Location of Testing (Point of care testing, Laboratory testing)

Geographical Segmentation

North America (U.S., Canada, Mexico) Europe (UK, Germany, France, Rest of Europe), Asia-Pacific (China, Japan, Australia, India, Rest of APAC), Rest of the World (Latin America, Middle East, Africa)

Companies Profiled

Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Alere Inc., Bio-Rad Laboratories, Becton, Dickinson and Company, BioMerieux, Beckman Coulter, Randox laboratories, and Thermo Fisher Scientific.
column chart pie chart

Test

1.... INTRODUCTION

1.1.           REPORT DESCRIPTION

1.2.           Research Methodology

1.2.1             Secondary Research

1.2.2             Data Analysis Framework

1.2.3             Market size estimation

1.2.4             Forecasting

1.2.5             Primary Research and Data Validation

2.... MARKET SNAPSHOT, 2019-2030 Million USD

2.1.           MARKET SNAPSHOT

3.... PORTER’S FIVE FORCE MODEL ANALYSIS

4.... MARKET DYNAMICS

4.1.           GROWTH DRIVERS

4.1.1             DRIVER 1

4.1.2             DRIVER 2

4.1.3             DRIVER 3

4.1.4             DRIVER 4

4.2.           CHALLENGES

4.2.1             CHALLENGE 1

4.2.2             CHALLENGE 2

4.3.           OPPORTUNITIES

4.3.1             OPPORTUNITY 1

4.3.2             OPPORTUNITY 2

5.... Global  Cardiac Biomarkers Market, By Type

5.1.           Overview

5.2.           Creatine Kinase

5.2.1             Creatine Kinase Market, By Region

5.2.1.1        North America Creatine Kinase Market, By Country

5.2.1.2        Europe Creatine Kinase Market, By Country

5.2.1.3        Asia-Pacific Creatine Kinase Market, By Country

5.2.1.4        Rest of World Creatine Kinase Market, By Country

5.3.           Troponins

5.3.1             Troponins Market, By Region

5.3.1.1        North America Troponins Market, By Country

5.3.1.2        Europe Troponins Market, By Country

5.3.1.3        Asia-Pacific Troponins Market, By Country

5.3.1.4        Rest of World Troponins Market, By Country

5.4.           Myoglobin

5.4.1             Myoglobin Market, By Region

5.4.1.1        North America Myoglobin Market, By Country

5.4.1.2        Europe Myoglobin Market, By Country

5.4.1.3        Asia-Pacific Myoglobin Market, By Country

5.4.1.4        Rest of World Myoglobin Market, By Country

5.5.           Natriuretic peptides

5.5.1             Natriuretic peptides Market, By Region

5.5.1.1        North America Natriuretic peptides Market, By Country

5.5.1.2        Europe Natriuretic peptides Market, By Country

5.5.1.3        Asia-Pacific Natriuretic peptides Market, By Country

5.5.1.4        Rest of World Natriuretic peptides Market, By Country

5.6.           Ischemia Modified Albumin

5.6.1             Ischemia Modified Albumin Market, By Region

5.6.1.1        North America Ischemia Modified Albumin Market, By Country

5.6.1.2        Europe Ischemia Modified Albumin Market, By Country

5.6.1.3        Asia-Pacific Ischemia Modified Albumin Market, By Country

5.6.1.4        Rest of World Ischemia Modified Albumin Market, By Country

5.7.           Other Type

5.7.1             Other Type Market, By Region

5.7.1.1        North America Other Type Market, By Country

5.7.1.2        Europe Other Type Market, By Country

5.7.1.3        Asia-Pacific Other Type Market, By Country

5.7.1.4        Rest of World Other Type Market, By Country

6.... Global  Cardiac Biomarkers Market, By Application

6.1.           Overview

6.2.           Myocardial Infarction

6.2.1             Myocardial Infarction Market, By Region

6.2.1.1        North America Myocardial Infarction Market, By Country

6.2.1.2        Europe Myocardial Infarction Market, By Country

6.2.1.3        Asia-Pacific Myocardial Infarction Market, By Country

6.2.1.4        Rest of World Myocardial Infarction Market, By Country

6.3.           Congestive Heart Failure

6.3.1             Congestive Heart Failure Market, By Region

6.3.1.1        North America Congestive Heart Failure Market, By Country

6.3.1.2        Europe Congestive Heart Failure Market, By Country

6.3.1.3        Asia-Pacific Congestive Heart Failure Market, By Country

6.3.1.4        Rest of World Congestive Heart Failure Market, By Country

6.4.           Acute Coronary Syndrome

6.4.1             Acute Coronary Syndrome Market, By Region

6.4.1.1        North America Acute Coronary Syndrome Market, By Country

6.4.1.2        Europe Acute Coronary Syndrome Market, By Country

6.4.1.3        Asia-Pacific Acute Coronary Syndrome Market, By Country

6.4.1.4        Rest of World Acute Coronary Syndrome Market, By Country

6.5.           Atherosclerosis

6.5.1             Atherosclerosis Market, By Region

6.5.1.1        North America Atherosclerosis Market, By Country

6.5.1.2        Europe Atherosclerosis Market, By Country

6.5.1.3        Asia-Pacific Atherosclerosis Market, By Country

6.5.1.4        Rest of World Atherosclerosis Market, By Country

6.6.           Other Application

6.6.1             Other Application Market, By Region

6.6.1.1        North America Other Application Market, By Country

6.6.1.2        Europe Other Application Market, By Country

6.6.1.3        Asia-Pacific Other Application Market, By Country

6.6.1.4        Rest of World Other Application Market, By Country

7.... Global  Cardiac Biomarkers Market, By Location of Testing

7.1.           Overview

7.2.           Point of care testing

7.2.1             Point of care testing Market, By Region

7.2.1.1        North America Point of care testing Market, By Country

7.2.1.2        Europe Point of care testing Market, By Country

7.2.1.3        Asia-Pacific Point of care testing Market, By Country

7.2.1.4        Rest of World Point of care testing Market, By Country

7.3.           Laboratory testing

7.3.1             Laboratory testing Market, By Region

7.3.1.1        North America Laboratory testing Market, By Country

7.3.1.2        Europe Laboratory testing Market, By Country

7.3.1.3        Asia-Pacific Laboratory testing Market, By Country

7.3.1.4        Rest of World Laboratory testing Market, By Country

8.... Global  Cardiac Biomarkers Market, By Region

8.1.           Overview

8.2.           North America

8.2.1             North America Cardiac Biomarkers Market, By Type

8.2.2             North America Cardiac Biomarkers Market, By Application

8.2.3             North America Cardiac Biomarkers Market, By Location of Testing

8.2.4             North America Cardiac Biomarkers, Market By Country

8.2.4.1        U.S.

8.2.4.1.1        U.S. Cardiac Biomarkers Market, By Type

8.2.4.1.2        U.S. Cardiac Biomarkers Market, By Application

8.2.4.1.3        U.S. Cardiac Biomarkers Market, By Location of Testing

8.2.4.2        Canada

8.2.4.2.1        Canada Cardiac Biomarkers Market, By Type

8.2.4.2.2        Canada Cardiac Biomarkers Market, By Application

8.2.4.2.3        Canada Cardiac Biomarkers Market, By Location of Testing

8.2.4.3        Mexico

8.2.4.3.1        Mexico Cardiac Biomarkers Market, By Type

8.2.4.3.2        Mexico Cardiac Biomarkers Market, By Application

8.2.4.3.3        Mexico Cardiac Biomarkers Market, By Location of Testing

8.3.           Europe

8.3.1             Europe Cardiac Biomarkers Market, By Type

8.3.2             Europe Cardiac Biomarkers Market, By Application

8.3.3             Europe Cardiac Biomarkers Market, By Location of Testing

8.3.4             Europe Cardiac Biomarkers, Market By Country

8.3.4.1        Germany

8.3.4.1.1        Germany Cardiac Biomarkers Market, By Type

8.3.4.1.2        Germany Cardiac Biomarkers Market, By Application

8.3.4.1.3        Germany Cardiac Biomarkers Market, By Location of Testing

8.3.4.2        UK

8.3.4.2.1        UK Cardiac Biomarkers Market, By Type

8.3.4.2.2        UK Cardiac Biomarkers Market, By Application

8.3.4.2.3        UK Cardiac Biomarkers Market, By Location of Testing

8.3.4.3        France

8.3.4.3.1        France Cardiac Biomarkers Market, By Type

8.3.4.3.2        France Cardiac Biomarkers Market, By Application

8.3.4.3.3        France Cardiac Biomarkers Market, By Location of Testing

8.3.4.4        Rest of Europe

8.3.4.4.1        Rest of Europe Cardiac Biomarkers Market, By Type

8.3.4.4.2        Rest of Europe Cardiac Biomarkers Market, By Application

8.3.4.4.3        Rest of Europe Cardiac Biomarkers Market, By Location of Testing

8.4.           Asia-Pacific

8.4.1             Asia-Pacific Cardiac Biomarkers Market, By Type

8.4.2             Asia-Pacific Cardiac Biomarkers Market, By Application

8.4.3             Asia-Pacific Cardiac Biomarkers Market, By Location of Testing

8.4.4             Asia-Pacific Cardiac Biomarkers, Market By Country

8.4.4.1        Japan

8.4.4.1.1        Japan Cardiac Biomarkers Market, By Type

8.4.4.1.2        Japan Cardiac Biomarkers Market, By Application

8.4.4.1.3        Japan Cardiac Biomarkers Market, By Location of Testing

8.4.4.2        India

8.4.4.2.1        India Cardiac Biomarkers Market, By Type

8.4.4.2.2        India Cardiac Biomarkers Market, By Application

8.4.4.2.3        India Cardiac Biomarkers Market, By Location of Testing

8.4.4.3        China

8.4.4.3.1        China Cardiac Biomarkers Market, By Type

8.4.4.3.2        China Cardiac Biomarkers Market, By Application

8.4.4.3.3        China Cardiac Biomarkers Market, By Location of Testing

8.4.4.4        Australia

8.4.4.4.1        Australia Cardiac Biomarkers Market, By Type

8.4.4.4.2        Australia Cardiac Biomarkers Market, By Application

8.4.4.4.3        Australia Cardiac Biomarkers Market, By Location of Testing

8.4.4.5        Rest of Asia-Pacific

8.4.4.5.1        Rest of Asia-Pacific Cardiac Biomarkers Market, By Type

8.4.4.5.2        Rest of Asia-Pacific Cardiac Biomarkers Market, By Application

8.4.4.5.3        Rest of Asia-Pacific Cardiac Biomarkers Market, By Location of Testing

8.5.           Rest of World

8.5.1             Rest of World Cardiac Biomarkers Market, By Type

8.5.2             Rest of World Cardiac Biomarkers Market, By Application

8.5.3             Rest of World Cardiac Biomarkers Market, By Location of Testing

8.5.4             Rest of World Cardiac Biomarkers, Market By Country

8.5.4.1        Latin America

8.5.4.1.1        Latin America Cardiac Biomarkers Market, By Type

8.5.4.1.2        Latin America Cardiac Biomarkers Market, By Application

8.5.4.1.3        Latin America Cardiac Biomarkers Market, By Location of Testing

8.5.4.2        Middle East

8.5.4.2.1        Middle East Cardiac Biomarkers Market, By Type

8.5.4.2.2        Middle East Cardiac Biomarkers Market, By Application

8.5.4.2.3        Middle East Cardiac Biomarkers Market, By Location of Testing

8.5.4.3        Africa

8.5.4.3.1        Africa Cardiac Biomarkers Market, By Type

8.5.4.3.2        Africa Cardiac Biomarkers Market, By Application

8.5.4.3.3        Africa Cardiac Biomarkers Market, By Location of Testing

9.... COMPANY PROFILES

9.1.           Abbott laboratories

9.1.1             COMPANY OVERVIEW

9.1.2             COMPANY SNAPSHOT

9.1.3             OPERATING BUSINESS SEGMENTS

9.1.4             PRODUCT PORTFOLIO

9.1.5             BUSINESS PERFORMANCE

9.1.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.2.           Alere Inc.

9.2.1             COMPANY OVERVIEW

9.2.2             COMPANY SNAPSHOT

9.2.3             OPERATING BUSINESS SEGMENTS

9.2.4             PRODUCT PORTFOLIO

9.2.5             BUSINESS PERFORMANCE

9.2.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.3.           Siemens Healthcare

9.3.1             COMPANY OVERVIEW

9.3.2             COMPANY SNAPSHOT

9.3.3             OPERATING BUSINESS SEGMENTS

9.3.4             PRODUCT PORTFOLIO

9.3.5             BUSINESS PERFORMANCE

9.3.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.4.           Roche Diagnostics Corporation

9.4.1             COMPANY OVERVIEW

9.4.2             COMPANY SNAPSHOT

9.4.3             OPERATING BUSINESS SEGMENTS

9.4.4             PRODUCT PORTFOLIO

9.4.5             BUSINESS PERFORMANCE

9.4.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.5.           Beckman Coulter

9.5.1             COMPANY OVERVIEW

9.5.2             COMPANY SNAPSHOT

9.5.3             OPERATING BUSINESS SEGMENTS

9.5.4             PRODUCT PORTFOLIO

9.5.5             BUSINESS PERFORMANCE

9.5.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.6.           Becton, Dickinson And Co.

9.6.1             COMPANY OVERVIEW

9.6.2             COMPANY SNAPSHOT

9.6.3             OPERATING BUSINESS SEGMENTS

9.6.4             PRODUCT PORTFOLIO

9.6.5             BUSINESS PERFORMANCE

9.6.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.7.           Thermo Fisher Scientific

9.7.1             COMPANY OVERVIEW

9.7.2             COMPANY SNAPSHOT

9.7.3             OPERATING BUSINESS SEGMENTS

9.7.4             PRODUCT PORTFOLIO

9.7.5             BUSINESS PERFORMANCE

9.7.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.8.           BioMerieux

9.8.1             COMPANY OVERVIEW

9.8.2             COMPANY SNAPSHOT

9.8.3             OPERATING BUSINESS SEGMENTS

9.8.4             PRODUCT PORTFOLIO

9.8.5             BUSINESS PERFORMANCE

9.8.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.9.           Bio-Rad Laboratories

9.9.1             COMPANY OVERVIEW

9.9.2             COMPANY SNAPSHOT

9.9.3             OPERATING BUSINESS SEGMENTS

9.9.4             PRODUCT PORTFOLIO

9.9.5             BUSINESS PERFORMANCE

9.9.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.10.         Randox laboratories

9.10.1           COMPANY OVERVIEW

9.10.2           COMPANY SNAPSHOT

9.10.3           OPERATING BUSINESS SEGMENTS

9.10.4           PRODUCT PORTFOLIO

9.10.5           BUSINESS PERFORMANCE

9.10.6           KEY STRATEGIC MOVES AND DEVELOPMENT

LIST OF TABLES

TABLE 1.         Global  Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 2.         Creatine Kinase Market Value, By Region, 2019-2030, Million USD

TABLE 3.         North America Creatine Kinase Market Value, By Country, 2019-2030, Million USD

TABLE 4.         Europe Creatine Kinase Market Value, By Country, 2019-2030, Million USD

TABLE 5.         Asia-Pacific Creatine Kinase Market Value, By Country, 2019-2030, Million USD

TABLE 6.         Rest of World Creatine Kinase Market Value, By Country, 2019-2030, Million USD

TABLE 7.         Troponins Market Value, By Region, 2019-2030, Million USD

TABLE 8.         North America Troponins Market Value, By Country, 2019-2030, Million USD

TABLE 9.         Europe Troponins Market Value, By Country, 2019-2030, Million USD

TABLE 10.       Asia-Pacific Troponins Market Value, By Country, 2019-2030, Million USD

TABLE 11.       Rest of World Troponins Market Value, By Country, 2019-2030, Million USD

TABLE 12.       Myoglobin Market Value, By Region, 2019-2030, Million USD

TABLE 13.       North America Myoglobin Market Value, By Country, 2019-2030, Million USD

TABLE 14.       Europe Myoglobin Market Value, By Country, 2019-2030, Million USD

TABLE 15.       Asia-Pacific Myoglobin Market Value, By Country, 2019-2030, Million USD

TABLE 16.       Rest of World Myoglobin Market Value, By Country, 2019-2030, Million USD

TABLE 17.       Natriuretic peptides Market Value, By Region, 2019-2030, Million USD

TABLE 18.       North America Natriuretic peptides Market Value, By Country, 2019-2030, Million USD

TABLE 19.       Europe Natriuretic peptides Market Value, By Country, 2019-2030, Million USD

TABLE 20.       Asia-Pacific Natriuretic peptides Market Value, By Country, 2019-2030, Million USD

TABLE 21.       Rest of World Natriuretic peptides Market Value, By Country, 2019-2030, Million USD

TABLE 22.       Ischemia Modified Albumin Market Value, By Region, 2019-2030, Million USD

TABLE 23.       North America Ischemia Modified Albumin Market Value, By Country, 2019-2030, Million USD

TABLE 24.       Europe Ischemia Modified Albumin Market Value, By Country, 2019-2030, Million USD

TABLE 25.       Asia-Pacific Ischemia Modified Albumin Market Value, By Country, 2019-2030, Million USD

TABLE 26.       Rest of World Ischemia Modified Albumin Market Value, By Country, 2019-2030, Million USD

TABLE 27.       Other Type Market Value, By Region, 2019-2030, Million USD

TABLE 28.       North America Other Type Market Value, By Country, 2019-2030, Million USD

TABLE 29.       Europe Other Type Market Value, By Country, 2019-2030, Million USD

TABLE 30.       Asia-Pacific Other Type Market Value, By Country, 2019-2030, Million USD

TABLE 31.       Rest of World Other Type Market Value, By Country, 2019-2030, Million USD

TABLE 32.       Global  Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 33.       Myocardial Infarction Market Value, By Region, 2019-2030, Million USD

TABLE 34.       North America Myocardial Infarction Market Value, By Country, 2019-2030, Million USD

TABLE 35.       Europe Myocardial Infarction Market Value, By Country, 2019-2030, Million USD

TABLE 36.       Asia-Pacific Myocardial Infarction Market Value, By Country, 2019-2030, Million USD

TABLE 37.       Rest of World Myocardial Infarction Market Value, By Country, 2019-2030, Million USD

TABLE 38.       Congestive Heart Failure Market Value, By Region, 2019-2030, Million USD

TABLE 39.       North America Congestive Heart Failure Market Value, By Country, 2019-2030, Million USD

TABLE 40.       Europe Congestive Heart Failure Market Value, By Country, 2019-2030, Million USD

TABLE 41.       Asia-Pacific Congestive Heart Failure Market Value, By Country, 2019-2030, Million USD

TABLE 42.       Rest of World Congestive Heart Failure Market Value, By Country, 2019-2030, Million USD

TABLE 43.       Acute Coronary Syndrome Market Value, By Region, 2019-2030, Million USD

TABLE 44.       North America Acute Coronary Syndrome Market Value, By Country, 2019-2030, Million USD

TABLE 45.       Europe Acute Coronary Syndrome Market Value, By Country, 2019-2030, Million USD

TABLE 46.       Asia-Pacific Acute Coronary Syndrome Market Value, By Country, 2019-2030, Million USD

TABLE 47.       Rest of World Acute Coronary Syndrome Market Value, By Country, 2019-2030, Million USD

TABLE 48.       Atherosclerosis Market Value, By Region, 2019-2030, Million USD

TABLE 49.       North America Atherosclerosis Market Value, By Country, 2019-2030, Million USD

TABLE 50.       Europe Atherosclerosis Market Value, By Country, 2019-2030, Million USD

TABLE 51.       Asia-Pacific Atherosclerosis Market Value, By Country, 2019-2030, Million USD

TABLE 52.       Rest of World Atherosclerosis Market Value, By Country, 2019-2030, Million USD

TABLE 53.       Other Application Market Value, By Region, 2019-2030, Million USD

TABLE 54.       North America Other Application Market Value, By Country, 2019-2030, Million USD

TABLE 55.       Europe Other Application Market Value, By Country, 2019-2030, Million USD

TABLE 56.       Asia-Pacific Other Application Market Value, By Country, 2019-2030, Million USD

TABLE 57.       Rest of World Other Application Market Value, By Country, 2019-2030, Million USD

TABLE 58.       Global  Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 59.       Point of care testing Market Value, By Region, 2019-2030, Million USD

TABLE 60.       North America Point of care testing Market Value, By Country, 2019-2030, Million USD

TABLE 61.       Europe Point of care testing Market Value, By Country, 2019-2030, Million USD

TABLE 62.       Asia-Pacific Point of care testing Market Value, By Country, 2019-2030, Million USD

TABLE 63.       Rest of World Point of care testing Market Value, By Country, 2019-2030, Million USD

TABLE 64.       Laboratory testing Market Value, By Region, 2019-2030, Million USD

TABLE 65.       North America Laboratory testing Market Value, By Country, 2019-2030, Million USD

TABLE 66.       Europe Laboratory testing Market Value, By Country, 2019-2030, Million USD

TABLE 67.       Asia-Pacific Laboratory testing Market Value, By Country, 2019-2030, Million USD

TABLE 68.       Rest of World Laboratory testing Market Value, By Country, 2019-2030, Million USD

TABLE 69.       Global  Cardiac Biomarkers Market Value, By Region, 2019-2030, Million USD

TABLE 70.       North America Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 71.       North America Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 72.       North America Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 73.       U.S. Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 74.       U.S. Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 75.       U.S. Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 76.       Canada Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 77.       Canada Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 78.       Canada Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 79.       Mexico Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 80.       Mexico Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 81.       Mexico Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 82.       Europe Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 83.       Europe Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 84.       Europe Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 85.       Germany Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 86.       Germany Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 87.       Germany Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 88.       UK Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 89.       UK Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 90.       UK Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 91.       France Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 92.       France Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 93.       France Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 94.       Rest of Europe Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 95.       Rest of Europe Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 96.       Rest of Europe Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 97.       Asia-Pacific Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 98.       Asia-Pacific Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 99.       Asia-Pacific Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 100.    Japan Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 101.    Japan Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 102.    Japan Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 103.    India Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 104.    India Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 105.    India Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 106.    China Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 107.    China Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 108.    China Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 109.    Australia Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 110.    Australia Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 111.    Australia Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 112.    Rest of Asia-Pacific Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 113.    Rest of Asia-Pacific Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 114.    Rest of Asia-Pacific Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 115.    Rest of World Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 116.    Rest of World Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 117.    Rest of World Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 118.    Latin America Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 119.    Latin America Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 120.    Latin America Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 121.    Middle East Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 122.    Middle East Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 123.    Middle East Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 124.    Africa Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

TABLE 125.    Africa Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

TABLE 126.    Africa Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

TABLE 127.    Abbott laboratories: COMPANY SNAPSHOT

TABLE 128.    Abbott laboratories: OPERATING SEGMENTS

TABLE 129.    Abbott laboratories: PRODUCT PORTFOLIO

TABLE 130.    Abbott laboratories: KEY STRATERGY

TABLE 131.    Alere Inc.: COMPANY SNAPSHOT

TABLE 132.    Alere Inc.: OPERATING SEGMENTS

TABLE 133.    Alere Inc.: PRODUCT PORTFOLIO

TABLE 134.    Alere Inc.: KEY STRATERGY

TABLE 135.    Siemens Healthcare: COMPANY SNAPSHOT

TABLE 136.    Siemens Healthcare: OPERATING SEGMENTS

TABLE 137.    Siemens Healthcare: PRODUCT PORTFOLIO

TABLE 138.    Siemens Healthcare: KEY STRATERGY

TABLE 139.    Roche Diagnostics Corporation: COMPANY SNAPSHOT

TABLE 140.    Roche Diagnostics Corporation: OPERATING SEGMENTS

TABLE 141.    Roche Diagnostics Corporation: PRODUCT PORTFOLIO

TABLE 142.    Roche Diagnostics Corporation: KEY STRATERGY

TABLE 143.    Beckman Coulter: COMPANY SNAPSHOT

TABLE 144.    Beckman Coulter: OPERATING SEGMENTS

TABLE 145.    Beckman Coulter: PRODUCT PORTFOLIO

TABLE 146.    Beckman Coulter: KEY STRATERGY

TABLE 147.    Becton, Dickinson And Co.: COMPANY SNAPSHOT

TABLE 148.    Becton, Dickinson And Co.: OPERATING SEGMENTS

TABLE 149.    Becton, Dickinson And Co.: PRODUCT PORTFOLIO

TABLE 150.    Becton, Dickinson And Co.: KEY STRATERGY

TABLE 151.    Thermo Fisher Scientific: COMPANY SNAPSHOT

TABLE 152.    Thermo Fisher Scientific: OPERATING SEGMENTS

TABLE 153.    Thermo Fisher Scientific: PRODUCT PORTFOLIO

TABLE 154.    Thermo Fisher Scientific: KEY STRATERGY

TABLE 155.    BioMerieux: COMPANY SNAPSHOT

TABLE 156.    BioMerieux: OPERATING SEGMENTS

TABLE 157.    BioMerieux: PRODUCT PORTFOLIO

TABLE 158.    BioMerieux: KEY STRATERGY

TABLE 159.    Bio-Rad Laboratories: COMPANY SNAPSHOT

TABLE 160.    Bio-Rad Laboratories: OPERATING SEGMENTS

TABLE 161.    Bio-Rad Laboratories: PRODUCT PORTFOLIO

TABLE 162.    Bio-Rad Laboratories: KEY STRATERGY

TABLE 163.    Randox laboratories: COMPANY SNAPSHOT

TABLE 164.    Randox laboratories: OPERATING SEGMENTS

TABLE 165.    Randox laboratories: PRODUCT PORTFOLIO

TABLE 166.    Randox laboratories: KEY STRATERGY

 

 

LIST OF FIGURES

FIGURE 1.       Global  Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 2.       Creatine Kinase Market Value, By Region, 2019-2030, Million USD

FIGURE 3.       North America Creatine Kinase Market Value, By Country, 2019-2030, Million USD

FIGURE 4.       Europe Creatine Kinase Market Value, By Country, 2019-2030, Million USD

FIGURE 5.       Asia-Pacific Creatine Kinase Market Value, By Country, 2019-2030, Million USD

FIGURE 6.       Rest of World Creatine Kinase Market Value, By Country, 2019-2030, Million USD

FIGURE 7.       Troponins Market Value, By Region, 2019-2030, Million USD

FIGURE 8.       North America Troponins Market Value, By Country, 2019-2030, Million USD

FIGURE 9.       Europe Troponins Market Value, By Country, 2019-2030, Million USD

FIGURE 10.     Asia-Pacific Troponins Market Value, By Country, 2019-2030, Million USD

FIGURE 11.     Rest of World Troponins Market Value, By Country, 2019-2030, Million USD

FIGURE 12.     Myoglobin Market Value, By Region, 2019-2030, Million USD

FIGURE 13.     North America Myoglobin Market Value, By Country, 2019-2030, Million USD

FIGURE 14.     Europe Myoglobin Market Value, By Country, 2019-2030, Million USD

FIGURE 15.     Asia-Pacific Myoglobin Market Value, By Country, 2019-2030, Million USD

FIGURE 16.     Rest of World Myoglobin Market Value, By Country, 2019-2030, Million USD

FIGURE 17.     Natriuretic peptides Market Value, By Region, 2019-2030, Million USD

FIGURE 18.     North America Natriuretic peptides Market Value, By Country, 2019-2030, Million USD

FIGURE 19.     Europe Natriuretic peptides Market Value, By Country, 2019-2030, Million USD

FIGURE 20.     Asia-Pacific Natriuretic peptides Market Value, By Country, 2019-2030, Million USD

FIGURE 21.     Rest of World Natriuretic peptides Market Value, By Country, 2019-2030, Million USD

FIGURE 22.     Ischemia Modified Albumin Market Value, By Region, 2019-2030, Million USD

FIGURE 23.     North America Ischemia Modified Albumin Market Value, By Country, 2019-2030, Million USD

FIGURE 24.     Europe Ischemia Modified Albumin Market Value, By Country, 2019-2030, Million USD

FIGURE 25.     Asia-Pacific Ischemia Modified Albumin Market Value, By Country, 2019-2030, Million USD

FIGURE 26.     Rest of World Ischemia Modified Albumin Market Value, By Country, 2019-2030, Million USD

FIGURE 27.     Other Type Market Value, By Region, 2019-2030, Million USD

FIGURE 28.     North America Other Type Market Value, By Country, 2019-2030, Million USD

FIGURE 29.     Europe Other Type Market Value, By Country, 2019-2030, Million USD

FIGURE 30.     Asia-Pacific Other Type Market Value, By Country, 2019-2030, Million USD

FIGURE 31.     Rest of World Other Type Market Value, By Country, 2019-2030, Million USD

FIGURE 32.     Global  Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 33.     Myocardial Infarction Market Value, By Region, 2019-2030, Million USD

FIGURE 34.     North America Myocardial Infarction Market Value, By Country, 2019-2030, Million USD

FIGURE 35.     Europe Myocardial Infarction Market Value, By Country, 2019-2030, Million USD

FIGURE 36.     Asia-Pacific Myocardial Infarction Market Value, By Country, 2019-2030, Million USD

FIGURE 37.     Rest of World Myocardial Infarction Market Value, By Country, 2019-2030, Million USD

FIGURE 38.     Congestive Heart Failure Market Value, By Region, 2019-2030, Million USD

FIGURE 39.     North America Congestive Heart Failure Market Value, By Country, 2019-2030, Million USD

FIGURE 40.     Europe Congestive Heart Failure Market Value, By Country, 2019-2030, Million USD

FIGURE 41.     Asia-Pacific Congestive Heart Failure Market Value, By Country, 2019-2030, Million USD

FIGURE 42.     Rest of World Congestive Heart Failure Market Value, By Country, 2019-2030, Million USD

FIGURE 43.     Acute Coronary Syndrome Market Value, By Region, 2019-2030, Million USD

FIGURE 44.     North America Acute Coronary Syndrome Market Value, By Country, 2019-2030, Million USD

FIGURE 45.     Europe Acute Coronary Syndrome Market Value, By Country, 2019-2030, Million USD

FIGURE 46.     Asia-Pacific Acute Coronary Syndrome Market Value, By Country, 2019-2030, Million USD

FIGURE 47.     Rest of World Acute Coronary Syndrome Market Value, By Country, 2019-2030, Million USD

FIGURE 48.     Atherosclerosis Market Value, By Region, 2019-2030, Million USD

FIGURE 49.     North America Atherosclerosis Market Value, By Country, 2019-2030, Million USD

FIGURE 50.     Europe Atherosclerosis Market Value, By Country, 2019-2030, Million USD

FIGURE 51.     Asia-Pacific Atherosclerosis Market Value, By Country, 2019-2030, Million USD

FIGURE 52.     Rest of World Atherosclerosis Market Value, By Country, 2019-2030, Million USD

FIGURE 53.     Other Application Market Value, By Region, 2019-2030, Million USD

FIGURE 54.     North America Other Application Market Value, By Country, 2019-2030, Million USD

FIGURE 55.     Europe Other Application Market Value, By Country, 2019-2030, Million USD

FIGURE 56.     Asia-Pacific Other Application Market Value, By Country, 2019-2030, Million USD

FIGURE 57.     Rest of World Other Application Market Value, By Country, 2019-2030, Million USD

FIGURE 58.     Global  Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 59.     Point of care testing Market Value, By Region, 2019-2030, Million USD

FIGURE 60.     North America Point of care testing Market Value, By Country, 2019-2030, Million USD

FIGURE 61.     Europe Point of care testing Market Value, By Country, 2019-2030, Million USD

FIGURE 62.     Asia-Pacific Point of care testing Market Value, By Country, 2019-2030, Million USD

FIGURE 63.     Rest of World Point of care testing Market Value, By Country, 2019-2030, Million USD

FIGURE 64.     Laboratory testing Market Value, By Region, 2019-2030, Million USD

FIGURE 65.     North America Laboratory testing Market Value, By Country, 2019-2030, Million USD

FIGURE 66.     Europe Laboratory testing Market Value, By Country, 2019-2030, Million USD

FIGURE 67.     Asia-Pacific Laboratory testing Market Value, By Country, 2019-2030, Million USD

FIGURE 68.     Rest of World Laboratory testing Market Value, By Country, 2019-2030, Million USD

FIGURE 69.     Global  Cardiac Biomarkers Market Value, By Region, 2019-2030, Million USD

FIGURE 70.     North America Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 71.     North America Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 72.     North America Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 73.     U.S. Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 74.     U.S. Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 75.     U.S. Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 76.     Canada Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 77.     Canada Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 78.     Canada Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 79.     Mexico Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 80.     Mexico Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 81.     Mexico Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 82.     Europe Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 83.     Europe Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 84.     Europe Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 85.     Germany Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 86.     Germany Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 87.     Germany Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 88.     UK Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 89.     UK Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 90.     UK Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 91.     France Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 92.     France Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 93.     France Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 94.     Rest of Europe Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 95.     Rest of Europe Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 96.     Rest of Europe Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 97.     Asia-Pacific Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 98.     Asia-Pacific Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 99.     Asia-Pacific Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 100.  Japan Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 101.  Japan Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 102.  Japan Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 103.  India Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 104.  India Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 105.  India Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 106.  China Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 107.  China Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 108.  China Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 109.  Australia Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 110.  Australia Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 111.  Australia Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 112.  Rest of Asia-Pacific Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 113.  Rest of Asia-Pacific Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 114.  Rest of Asia-Pacific Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 115.  Rest of World Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 116.  Rest of World Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 117.  Rest of World Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 118.  Latin America Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 119.  Latin America Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 120.  Latin America Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 121.  Middle East Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 122.  Middle East Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 123.  Middle East Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 124.  Africa Cardiac Biomarkers Market Value, By Type, 2019-2030, Million USD

FIGURE 125.  Africa Cardiac Biomarkers Market Value, By Application, 2019-2030, Million USD

FIGURE 126.  Africa Cardiac Biomarkers Market Value, By Location of Testing, 2019-2030, Million USD

FIGURE 127.  Abbott laboratories: NET SALES,2017-2019

FIGURE 128.  Alere Inc.: NET SALES,2017-2019

FIGURE 129.  Siemens Healthcare: NET SALES,2017-2019

FIGURE 130.  Roche Diagnostics Corporation: NET SALES,2017-2019

FIGURE 131.  Beckman Coulter: NET SALES,2017-2019

FIGURE 132.  Becton, Dickinson And Co.: NET SALES,2017-2019

FIGURE 133.  Thermo Fisher Scientific: NET SALES,2017-2019

FIGURE 134.  BioMerieux: NET SALES,2017-2019

FIGURE 135.  Bio-Rad Laboratories: NET SALES,2017-2019

FIGURE 136.  Randox laboratories: NET SALES,2017-2019

KEY PLAYERS:

  • Roche Diagnostics

  • Siemens Healthcare

  • Abbott Laboratories

  • Alere Inc.

  • Bio-Rad Laboratories

  • Becton, Dickinson and Company

  • BioMerieux

  • Beckman Coulter

  • Randox laboratories

  • Thermo Fisher Scientific


Frequently Asked Questions
What will be the worth of global Cardiac Biomarkers Market by the end of 2030?

According to the report published by Next Move Strategy Consulting, the Cardiac Biomarkers market business is expected to hit at $28.29 billion (USD) by 2030.

Which region is expected to hold the highest market share in the Cardiac Biomarkers Market?

North America is expected to hold the highest market share in the global market. The region is expected to witness remarkable growth as it houses the major key players in the market.

Which are the top companies in the Cardiac Biomarkers industry?

Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Alere Inc., Bio-Rad Laboratories, Becton, Dickinson and Company, BioMerieux, Beckman Coulter, Randox laboratories, and Thermo Fisher Scientific

What are the market segmentations and scope of the study?

The global Cardiac Biomarkers market share is analyzed on the basis of type, application, location of testing and geography.

How big is the Cardiac Biomarkers Market?

Currently (in 2019), the market value stands at USD 8.42 billion and it is anticipated to reach USD 28.29 billion by 2030.